Results 41 to 50 of about 2,433 (185)

Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology [PDF]

open access: yes, 2019
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 requires that pharmacogenetic genotyping methods need to be established according to technical standards and laboratory practice guidelines before testing can be offered to patients.
Kiel, Patrick J.   +7 more
core   +1 more source

Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.

open access: yesPLoS ONE, 2020
IntroductionThe nudix hydrolase 15 (NUDT15) gene acts in the metabolism of thiopurine, by catabolizing its active metabolite thioguanosine triphosphate into its inactivated form, thioguanosine monophosphate.
Juliana Carla Gomes Rodrigues   +19 more
doaj   +1 more source

Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review [PDF]

open access: yesPrecision and Future Medicine, 2021
The development of treatment options has revolutionized the prognosis of inflammatory bowel disease (IBD). However, a particular group of patients still experience therapeutic failure or drug side effects.
Ji Young Chang, Jae Hee Cheon
doaj   +1 more source

Expression of oxidative stress and antioxidant defense genes in the kidney of inbred mice after intestinal ischemia and reperfusion [PDF]

open access: yes, 2013
PURPOSE: To determine the gene expressions profile related to the oxidative stress and the antioxidant response in the kidneys of mice subjected to intestinal ischemia and reperfusion.
Bertoletto, Paulo Roberto   +6 more
core   +2 more sources

Genomic medicine in inflammatory bowel disease [PDF]

open access: yes, 2020
Inflammatory bowel disease (IBD) is a term for two conditions (Crohn’s disease [CD] and ulcerative colitis [UC]) that are characterised by chronic inflammation of the gastrointestinal tract.
Voskuil, Michiel
core   +2 more sources

6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients [PDF]

open access: yes, 2017
Background and Aim: Thiopurines have a favorable benefit–risk ratio in the treatment of inflammatory bowel disease. A feared adverse event of thiopurine therapy is myelotoxicity, mostly occurring due to toxic concentrations of the pharmacologically ...
Bodegraven, A.A. (Ad) van   +9 more
core   +3 more sources

NUDT15: a novel player in thiopurine metabolism

open access: yesJournal of Gastrointestinal and Liver Diseases, 2016
.
Meijer, Berrie   +2 more
openaire   +3 more sources

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. [PDF]

open access: yes, 2016
Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are available for their treatment. Our previous analyses have identified potential kinase targets critical for the growth of ER-negative, progesterone receptor (PR)-
Brown, Powel H   +13 more
core   +2 more sources

Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation [PDF]

open access: yes, 2023
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.biopha.2023.115706Azathioprine is commonly used as an immunosuppressive antimetabolite in the treatment of acute lymphoblastic leukemia, autoimmune ...
Cabeza Barrera, José   +7 more
core   +1 more source

Second Korean Guideline for the Management of Ulcerative Colitis [PDF]

open access: yes, 2017
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during ...
���������
core   +1 more source

Home - About - Disclaimer - Privacy